Dr. Reddys Laboratories Ltd.

Dr. Reddy's Laboratories has reported results for fourth quarter (Q4) and year ended March 31, 2023.

The company has reported 60.21% rise in its net profit at Rs 672.40 crore for the quarter under review as compared to Rs 419.70 crore for the same quarter in the previous year. Total income of the company increased by 23.40% at Rs 4,668.80 crore for Q4FY23 as compared to Rs 3,783.40 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported around 10-fold jump in net profit at Rs 960.10 crore for fourth quarter ended March 31, 2023 as compared to Rs 97.00 crore for the same quarter in the previous year. Total income of the company increased by 15.31% at Rs 6,453.70 crore for Q4FY23 as compared to Rs 5,596.80 crore for the corresponding quarter previous year.

For the year ended March 31, 2023, the company has reported rise of 60.97% in its net profit at Rs 2,612.80 crore as compared to Rs 1,623.20 crore for the previous year. Total income of the company increased by 17.91% at Rs 17,553.80 crore for year under review as compared to Rs 14,887.20 crore for year ended March 31, 2022.

For the year ended March 31, 2023, on the consolidated basis, the company has reported over 2-fold rise in its net profit at Rs 4,507.30 crore as compared to Rs 2,182.50 crore for the previous year. Total income of the company increased by 16.78% at Rs 25,725.20 crore for year under review as compared to Rs 22,029.60 crore for year ended March 31, 2022.